Latest News and Press Releases

Lehi, June 19, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 19, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to...

Lehi, Utah, June 09, 2025 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today...

Lehi, June 05, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 5, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform designed to use the body’s immune...

Lehi, June 03, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 3rd, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform that will use the body’s immune...

Lehi, UT, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Lehi, UT, February 27, 2025 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a revolutionary universal cancer treatment platform that will use the...

Lehi, UT, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – February 25, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform that will use the body’s...

Lehi, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- CancerVax Passes First Test with Flying Colors Recent in-vitro lab results confirm that the Company’s Smart mRNA can be used as a potential on/off...

Lehi, UT, Dec. 11, 2024 (GLOBE NEWSWIRE) -- CancerVax Targets Hard to Treat Pancreatic Cancer With limited options available to treat Pancreatic Ductal Adenocarcinoma (PDAC), the Company’s...

Lehi, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Dr. George Katibah to serve as the Company’s Chief Scientific Officer Lehi, UT, November 19, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of...

Santa Barbara, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, August 29, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that will...